Optain Health, a startup that built artificial-intelligence-powered retinal screening technology, acquired EyePACS to add its teleophthalmology network and expand access to eye disease screening in ...

Please provide your email address to receive an email when new articles are posted on . AEYE Health has received the first-ever FDA clearance for a fully autonomous AI that can diagnose referable ...

Some hospitals are finding it difficult to scale AI across their enterprise — with this process often complicated by things like inadequate technology infrastructures, varying needs across specialties ...

Please provide your email address to receive an email when new articles are posted on . The use of artificial intelligence in screening for diabetic retinopathy led to accurate referrals in Rwanda ...

Diabetes is often called a silent disease and nowhere is this more evident than in the eyes. Many people assume vision problems occur only later in life, but diabetic eye damage can begin much earlier ...

The preparation of evidence-based guidelines is highlighted by the WHO as an important component in the concerted effort to eliminate avoidable blindness. [149] This review has highlighted ...

Retinal tear surgery and retinal detachment surgery are distinct medical procedures. The retina is a thin layer of light-sensitive tissue at the back of your eyes. Your eye lens focuses light onto ...

Recent reports suggest diabetic retinopathy is more common in younger people than previously thought, leading to a call for more frequent screening for this condition and more attention to follow-up ...

AI-based retinal imaging and diagnostics startup AEYE Health announced today it received clearance from the FDA to market its diagnostic screening system for diabetic retinopathy. There are 35 million ...

However, changes in eyesight alone are not a reliable indicator of diabetes, as vision problems can also occur due to ageing, refractive errors, or other eye conditions. Regular eye screening and ...